Company / Operating Income per Share
NovoCure Ltd Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.42
FY2025
5-year range
-$2.22 / -$0.43
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#122 of 149
Health Care
What the data says
NovoCure Ltd's operating income per share of $-1.42 is lower than 82% of companies in the Health Care sector (FY2025). Improved from $-2.22 to $-1.42 over the past 2 years.
Based on SEC 10-K filings.
-1.42 in FY2025.
Improved from $-2.22 to $-1.42 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 149This company -$1.42 Sector average $4.30
▼
-133.0% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 11.0% year-over-year.
- Ranks #122 out of 149 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.42 | +11.0% |
| FY2024 | -$1.59 | +28.2% |
| FY2023 | -$2.22 | -157.5% |
| FY2022 | -$0.86 | -98.8% |
| FY2021 | -$0.43 | -241.8% |
| FY2020 | $0.31 | +3216.5% |
| FY2019 | -$0.01 | +97.4% |
| FY2018 | -$0.38 | +16.7% |
| FY2017 | -$0.45 | +67.2% |
| FY2016 | -$1.38 | +82.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026